SCHEMBL3567228

SCHEMBL3567228

Nc1cncnc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 4/20 0.44
TDP1 Q9NUW8 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM6B O15054 1/20 0.44
KDM4A O75164 1/20 0.44
THRB P10828 1/20 0.44
KDM4D Q6B0I6 1/20 0.44
KDM4C Q9H3R0 1/20 0.44
HCAR2 Q8TDS4 2/20 0.43
GABRP O00591 3/20 0.36
GABRD O14764 3/20 0.36
GABRA1 P14867 3/20 0.36
GABRB1 P18505 3/20 0.36
GABRG2 P18507 3/20 0.36
GABRB3 P28472 3/20 0.36
GABRA5 P31644 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956728 1.00 KDM4E (0.44) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL28170830 0.83 NNMT (0.41) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL7456714 0.76 ALDH1A1 (0.50) KDM4EALDH1A1MAPTL3MBTL1KDM4C
SCHEMBL68960 0.76 KDM4E (0.47) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL30978924 0.76 HCAR2 (0.44) KDM4EALDH1A1KMT2AMEN1MAPT
SCHEMBL352483 0.76 SPR (0.45) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL629032 0.76 HCAR2 (0.44) KDM4EALDH1A1KMT2AMEN1MAPT
SCHEMBL758324 0.74 NAPRT (0.48) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL9278316 0.74 MEN1 (0.46) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL20928646 0.74 HCAR2 (0.43) KDM4EALDH1A1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107176926-A A kind of preparation method of pyridine derivatives 湖南华腾制药有限公司 2017-09-19 CN claimed
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US claimed
WO-2025091127-A1 HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF UNIVERSITE DE MONTREAL (CA) 2025-05-08 WO disclosed
CN-111118482-A Chemical silver plating solution and application 深圳市正天伟科技有限公司 2020-05-08 CN disclosed
CN-109956942-A Tryptamines ketones derivant and application thereof 上海翔锦生物科技有限公司 2019-07-02 CN disclosed
CN-109322145-A Crease-resistant elastic force breathable fabric 潢川县圣宇服饰科技有限公司 2019-02-12 CN disclosed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
CN-107176926-A A kind of preparation method of pyridine derivatives 湖南华腾制药有限公司 2017-09-19 CN disclosed
CN-107176926-A A kind of preparation method of pyridine derivatives 湖南华腾制药有限公司 2017-09-19 CN disclosed
CN-102947292-B nitrogen-containing heteroaryl compounds HOFFMAN-LA ROCHE LTD. (CH) 2015-08-19 CN disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. 2007-09-20 US disclosed
CN-1319969-C Fungicides SYNGENTA LTD (GB) 2007-06-06 CN disclosed
EP-1513820-A4 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS INC (US) 2006-09-13 EP disclosed
US-20060111374-A1 Compounds, compositions, and methods CYTOKINETICS, INC. 2006-05-25 US disclosed
US-7038048-B2 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use CYTOKINETICS, INC. (US) 2006-05-02 US disclosed
CN-1732170-A Fungicidal agents SYNGENTA LTD (GB) 2006-02-08 CN disclosed
EP-1513820-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2005-03-16 EP disclosed
US-20040116438-A1 Compounds, compositions, and methods CYTOKINETICS, INCORPORATED 2004-06-17 US disclosed
WO-2003103575-A2 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2003-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111374-A1 Compounds, compositions, and methods ALPP, MKI67, PCNA KDM4E 1421/4885ALDH1A1 2342/4885TDP1 1140/4885
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds AADAT, AAAS, AADAC KDM4E 1828/4885ALDH1A1 1414/4885TDP1 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.